Psychiatry & Neurology Doctors in Lajolla, CA Accepting Medicare
1 Psychiatry & Neurology doctors found. Showing 1 - 1
 Mr. Eli Jerry Miller, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 9834 Genesee Ave Ste 420, Lajolla, CA 92037 Phone: 858-455-7364 Fax: 858-455-0053 |
News Archive
Merck provides update on MK-8931 investigational oral therapy for Alzheimer's disease
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for MK-8931, a novel investigational oral β-amyloid precursor protein site-cleaving enzyme (BACE) inhibitor.
UI researchers remind US doctors to watch for two diseases that could be passed from mother to child
While world health leaders race to contain the spread of the mosquito-borne Zika virus in the Americas, researchers at the University of Iowa are reminding doctors in the United States to be on the lookout for two other vector-borne and potentially life-threatening diseases that can be passed from mother to child through the placenta.
Study estimates incidence of first-episode psychosis in six countries
Young males, ethnic minorities and people living in socioeconomically disadvantaged areas are more likely to experience first-episode psychosis, defined as the first manifestation of one or more severe mental disorders including schizophrenia, bipolar affective disorder, and depression with psychotic symptoms such as hallucinations, delusions and cognitive disorganization.
Particle Metrix reports on use of Zetaview particle characterization system at University Hospital of Erlangen
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work of the Baur Laboratory in the Department of Dermatology at the University Hospital of Erlangen. The Group, which is part of the Translational Research Center at the University, is working to quantify extracellular vesicles in plasma of patients.
FemmePharma completes FP 1097 Phase II clinical trial in women with OAB
FemmePharma Global Healthcare, a privately held women's health company dedicated to improving the quality of life for women, today announces completion of its Phase II clinical dose ranging/safety trial with FP 1097 in women suffering from urinary incontinence or overactive bladder.
› Verified 7 days ago